CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

FDA Rare Disease Innovation Hub

Positive
AI Analysis

Summary

The FDA has established the Rare Disease Innovation Hub to facilitate collaboration between CBER and CDER with the goal of improving patient outcomes for rare diseases.

Importance:2/10
Sentiment:
0.30
rare_diseaseregulatory_initiativeFDAinnovation_hubCBERCDER

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on September 14, 2026 3:52 PM

Read Original